-
Medical Management of Erectile Dysfunction
Deepak K. Jumani, MBBS, FCGP, previews his presentation “Medical Management of Erectile Dysfunction,” which will begin at 1:15 p.m. CT Friday, June 12.
-
What Teens with Type 1 Do RIGHT—Equipping Parents and Providers to Build Youths’ Diabetes Strengths
Marisa E. Hilliard, PhD, discussed the concept of integrating positive psychology approaches into diabetes interventions during the Scientific Sessions. She presented research on intervention strategies designed to promote resilience in teens with diabetes by targeting family and health care systems.
-
Excess Heart Failure and Cardiovascular Disease Risk in Women with Diabetes—A Not-So-Sweet Truth
William B. Horton, MD, FACP, previews his presentation “Excess Heart Failure and Cardiovascular Disease Risk in Women with Diabetes—A Not-So-Sweet Truth,” which begins at 12:00 p.m. CT Sunday, June 14.
-
Beta-Cell Endoplasmic Reticulum Stress in Type 1 Diabetes
Feyza Engin, PhD, examined beta-cell endoplasmic reticulum stress in type 1 diabetes during the Scientific Sessions. Although immune dysregulation plays a vital role in type 1 diabetes pathogenesis, emerging data suggest that beta cells are not passive bystanders but play an active role in their own demise, she said.
-
Investigators will review latest findings from DAPA-HF study
Investigators from the Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure (DAPA-HF) will discuss the latest findings from the study during the 80th Virtual Scientific Sessions. Silvio E. Inzucchi, MD, will review the metabolic and safety aspects of DAPA-HF.
-
RISE Study continues to provide insight into progression of type 2 diabetes in youth
Ongoing data analyses from the New Insights from the Restoring Insulin Secretion (RISE) Study continue to shed light on important differences between adults and youth in the onset and progression of type 2 diabetes. A panel of RISE investigators, including RISE Steering Committee Chair Steven E. Kahn, MB, ChB, will discuss the latest findings at…
-
Researchers continue to investigate cardioprotective effects of GLP-1 receptor agonists
Glucagon-like peptide-1 (GLP-1) receptor agonists reduce the risk of myocardial infarction, stroke, and similar cardiovascular events, but questions remain about the mechanisms behind the cardioprotection the drugs provide. During a Virtual Scientific Sessions symposium, Daniel J. Drucker, MD, and two other researchers will address the question, How Do GLP-1 Receptor Agonists Provide Cardioprotection?
-
With limited health care dollars, do the benefits of CGM justify the additional costs in type 2 diabetes care?
During a virtual presentation at the Scientific Sessions, Athena Philis-Tsimikas, MD, and Elbert Huang, MD, MPH, FACP, will debate the value of continuous glucose monitoring (CGM) in patients with type 2 diabetes. ADAMeetingNews.org spoke to Drs. Philis-Tsimikas and Huang for a preview of the debate.
-
Expert panel to provide update on lipid-lowering drugs
Four experts will provide an update on lipid-lowering drugs during a two-hour virtual presentation at the Scientific Sessions. The session’s panelists include Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC; Jennifer G. Robinson, MD, MPH; and John R. Guyton, MD.
-
Scientific Sessions include four days of virtual networking opportunities for ADA members
ADA’s Interest Group Leadership Teams have been hard at work planning virtual networking events, which will allow members to linger virtually at the back of the lecture hall discussing new research, share perspectives on a variety of hot topics in diabetes, and contribute to the future planning of ADA’s Interest Group activities.